MedinCell S.A. (EPA:MEDCL)

Total Valuation

MedinCell has a market cap or net worth of EUR 560.58 million. The enterprise value is 556.01 million.

Market Cap	560.58M
Enterprise Value	556.01M

Important Dates

The next estimated earnings date is Tuesday, December 9, 2025.

Earnings Date	Dec 9, 2025
Ex-Dividend Date	n/a

Share Statistics

MedinCell has 33.09 million shares outstanding. The number of shares has increased by 4.28% in one year.

Current Share Class	33.09M
Shares Outstanding	33.09M
Shares Change (YoY)	+4.28%
Shares Change (QoQ)	+3.67%
Owned by Insiders (%)	13.93%
Owned by Institutions (%)	23.48%
Float	24.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.22
PB Ratio	-34.25
P/TBV Ratio	n/a
P/FCF Ratio	29.95
P/OCF Ratio	28.80
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.16
EV / Sales	20.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	29.70

Financial Position

The company has a current ratio of 2.70

Current Ratio	2.70
Quick Ratio	2.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	3.60
Interest Coverage	-2.12

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.56%
Return on Invested Capital (ROIC)	-17.98%
Return on Capital Employed (ROCE)	-17.77%
Revenue Per Employee	211,656
Profits Per Employee	-140,748
Employee Count	131
Asset Turnover	0.44
Inventory Turnover	n/a

Taxes

In the past 12 months, MedinCell has paid 160,000 in taxes.

Income Tax	160,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.93% in the last 52 weeks. The beta is 1.11, so MedinCell's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-7.93%
50-Day Moving Average	16.62
200-Day Moving Average	15.81
Relative Strength Index (RSI)	50.08
Average Volume (20 Days)	83,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedinCell had revenue of EUR 27.73 million and -18.44 million in losses. Loss per share was -0.62.

Revenue	27.73M
Gross Profit	27.73M
Operating Income	-10.76M
Pretax Income	-18.28M
Net Income	-18.44M
EBITDA	-10.07M
EBIT	-10.76M
Loss Per Share	-0.62

Balance Sheet

The company has 71.90 million in cash and 67.32 million in debt, giving a net cash position of 4.58 million or 0.14 per share.

Cash & Cash Equivalents	71.90M
Total Debt	67.32M
Net Cash	4.58M
Net Cash Per Share	0.14
Equity (Book Value)	-16.37M
Book Value Per Share	-0.49
Working Capital	50.74M

Cash Flow

In the last 12 months, operating cash flow was 19.47 million and capital expenditures -747,000, giving a free cash flow of 18.72 million.

Operating Cash Flow	19.47M
Capital Expenditures	-747,000
Free Cash Flow	18.72M
FCF Per Share	0.57

Margins

Gross margin is 100.00%, with operating and profit margins of -38.81% and -66.50%.

Gross Margin	100.00%
Operating Margin	-38.81%
Pretax Margin	-65.92%
Profit Margin	-66.50%
EBITDA Margin	-36.32%
EBIT Margin	-38.81%
FCF Margin	67.51%

Dividends & Yields

MedinCell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.28%
Shareholder Yield	n/a
Earnings Yield	-3.29%
FCF Yield	3.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedinCell has an Altman Z-Score of 2.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.84
Piotroski F-Score	4